Andrew R. Mariniello
Andrew R. Mariniello counsels clients on a wide variety of business law matters, with an emphasis on advising public and private companies and private equity firms in domestic and cross-border mergers and acquisitions. Andrew serves as co-leader of Morgan Lewis’s global M&A practice area and has over 20 years of experience representing private equity firms, venture capital investors, and privately held companies in acquisitions, dispositions, platform investments, early stage, and follow-on investments. Andrew helps clients navigate complex deals ranging from millions to billions of dollars across a variety of industries, including technology, life sciences, healthcare, data centers and infrastructure, manufacturing, and financial services.
Andrew also leads Morgan Lewis’s royalty finance practice. He regularly advises both investors and royalty holders in the structure and negotiation of traditional and synthetic royalty monetization transactions, royalty backed-loans, and related intercreditor arrangements primarily in the life sciences industry. Andrew’s representations include royalty investment funds, hedge funds, private equity funds, licensors, biopharma companies, and academic institutions in a variety of bespoke royalty-based financing transactions and structures.
Before joining Morgan Lewis, Andrew was a senior corporate associate in the New York office of a major international law firm. He received his J.D. from the University of Pennsylvania Law School, before which he worked as a financial analyst in the real estate investments department of an international insurance company in New York.
